Abstract
Purpose
Small studies have suggested that older patients have worse outcomes following radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB). We evaluated the association of patient age with clinical outcomes in a large multi-institutional RC series.
Methods
Data were collected from 4,429 patients treated with RC and lymphadenectomy for UCB without neoadjuvant chemotherapy. Age at RC was analyzed both as a continuous and categorical variable.
Results
Higher age at RC, analyzed as a continuous or categorical variable, was associated with advanced pathologic stage (P < 0.001), higher tumor grade (P = 0.045), presence of lymphovascular invasion (P = 0.018), and positive soft-tissue surgical margin status (P = 0.004). Elderly patients were less likely to receive postoperative chemotherapy (P < 0.001). In multivariable analyses, higher age was associated with disease recurrence, cancer-specific, and overall mortality (P < 0.001). Patients ≥80 years had a significantly greater risk of cancer-specific mortality than patients <50 years (HR 1.763, P < 0.001). Age minimally improved the accuracy of a base model that included standard pathologic features for prediction of disease recurrence (+0.2–0.3%) and cancer-specific survival (+0.3%). Conversely, age improved the predictive accuracy for overall survival by a sizeable margin (+4.2–4.5%).
Conclusions
This large external validation study confirms that advanced patient age is minimally but significantly associated with worse prognosis after RC. Nevertheless, a large proportion of elderly patients benefitted from RC with curative intent. We need to improve our understanding of the reasons for the worse UCB outcomes in this growing segment of the population and to develop strategies to improve cancer care in the elderly.
Similar content being viewed by others
Abbreviations
- UCB:
-
Urothelial carcinoma of the bladder
- RC:
-
Radical cystectomy
- LN:
-
Lymph nodes
References
Yancik R, Ries LA (2004) Cancer in older persons: an international issue in an aging world. Semin Oncol 31:128–136
Yancik R, Ries LA (2000) Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17–23
Edwards BK, Howe HL, Ries LA et al (2002) Annual report to the nation on the status of cancer, 1973–1999, featuring implications of age and aging on US cancer burden. Cancer 94:2766–2792
Hewitt M, Rowland JH, Yancik R (2003) Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 58:82–91
Lynch CF, Cohen MB (1995) Urinary system. Cancer 75:316–329
Schultzel M, Saltzstein SL, Downs TM, Shimasaki S, Sanders C, Sadler GR (2008) Late age (85 years or older) peak incidence of bladder cancer. J Urol 179:1302–1305; (discussion 5–6)
Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1, 054 patients. J Clin Oncol 19:666–675
Madersbacher S, Hochreiter W, Burkhard F et al (2003) Radical cystectomy for bladder cancer today–a homogeneous series without neoadjuvant therapy. J Clin Oncol 21:690–696
Shariat SF, Karakiewicz PI, Palapattu GS et al (2006) Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176:2414–2422; (discussion 22)
Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly. Urol Oncol 27:653–667
Prout GJ, Wesley M, Yancik R, Ries L, Havlik R, Edwards B (2005) Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 104:1638–1647
Hollenbeck BK, Miller DC, Taub D et al (2004) Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 64:292–297
Shabsigh A, Korets R, Vora KC et al (2009) Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 55:164–174
Isbarn H, Jeldres C, Zini L et al (2009) A population based assessment of perioperative mortality after cystectomy for bladder cancer. J Urol 182:70–77
Froehner M, Brausi MA, Herr HW, Muto G, Studer UE (2009) Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 56:443–454
Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW (2010) Radical cystectomy in octogenarians–does morbidity outweigh the potential survival benefits? J Urol 183:2171–2177
Stimson CJ, Chang SS, Barocas DA et al (2010) Early and late perioperative outcomes following radical cystectomy: 90-day readmissions, morbidity and mortality in a contemporary series. J Urol 184:1296–1300
Nielsen M, Shariat S, Karakiewicz P et al (2007) Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 51:699–706; (discussion 8)
Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H (2009) The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 103:480–483
Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
Nielsen M, Palapattu G, Karakiewicz P et al (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU Int 100:1015–1020
Chang S, Hassan J, Cookson M, Wells N, Smith JJ (2003) Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 170:1085–1087
Gore J, Litwin M, Lai J et al (2010) Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst 102:802–811
Konety B, Joslyn S (2003) Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 170:1765–1771
Clark P, Stein J, Groshen S et al (2005) Radical cystectomy in the elderly: comparison of clincal outcomes between younger and older patients. Cancer 104:36–43
Whitmore WF, Marshall VF (1962) Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol 87:853–868
Feifer AH, Taylor JM, Tarin TV, Herr HW (2011) Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapy. Eur Urol 59:978–984
Karl A, Carroll PR, Gschwend JE et al (2009) The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol 55:826–835
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
T. F. Chromecki and J. Mauermann are contributed equally.
Rights and permissions
About this article
Cite this article
Chromecki, T.F., Mauermann, J., Cha, E.K. et al. Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. World J Urol 30, 753–759 (2012). https://doi.org/10.1007/s00345-011-0772-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-011-0772-2